Search Results - "Prochazka, Katharina"

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia by Prochazka, Katharina T, Pregartner, Gudrun, Rücker, Frank G, Heitzer, Ellen, Pabst, Gabriel, Wölfler, Albert, Zebisch, Armin, Berghold, Andrea, Döhner, Konstanze, Sill, Heinz

“…The role of subclonal mutations, defined by a variant allele frequency of <20%, has not been addressed in acute myeloid leukemia yet. We, therefore, analyzed…”
Get full text

Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions by Pansy, Katrin, Uhl, Barbara, Krstic, Jelena, Szmyra, Marta, Fechter, Karoline, Santiso, Ana, Thüminger, Lea, Greinix, Hildegard, Kargl, Julia, Prochazka, Katharina, Feichtinger, Julia, Deutsch, Alexander Ja

“…The tumor microenvironment (TME) is a critical regulator of tumor growth, progression, and metastasis. Since immune cells represent a large fraction of the…”
Get full text

Chronic lymphocytic leukaemia—what is new and notable in 2021, with a special focus on COVID-19 by Prochazka, Katharina T., Neumeister, Peter

“…Summary In the last few years, treatment of patients exhibiting chronic lymphocytic leukaemia has changed extensively due to advances in the development of…”
Get full text

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients by Prochazka, Katharina T, Melchardt, Thomas, Posch, Florian, Schlick, Konstantin, Deutsch, Alexander, Beham-Schmid, Christine, Weiss, Lukas, Gary, Thomas, Neureiter, Daniel, Klieser, Eckhard, Greil, Richard, Neumeister, Peter, Egle, Alexander, Pichler, Martin

“…Background: Blood-based parameters are gaining increasing interest as potential prognostic biomarkers in patients with diffuse large B-cell lymphoma (DLBCL)…”
Get full text

Immunohistochemistry for c‐myc and bcl‐2 overexpression improves risk stratification in primary central nervous system lymphoma by Hatzl, Stefan, Posch, Florian, Deutsch, Alexander, Beham‐Schmid, Christine, Stöger, Herbert, Greinix, Hildegard, Pichler, Martin, Neumeister, Peter, Prochazka, Katharina T.

“…Overexpression of bcl‐2 and c‐myc are defining features of double‐expressor‐lymphoma (DEL) but may also occur separately in patients with primary central…”
Get full text

Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells by Uhl, Barbara, Prochazka, Katharina T, Pansy, Katrin, Wenzl, Kerstin, Strobl, Johanna, Baumgartner, Claudia, Szmyra, Marta M, Waha, James E, Wolf, Axel, Tomazic, Peter V, Steinbauer, Elisabeth, Steinwender, Maria, Friedl, Sabine, Weniger, Marc, Küppers, Ralf, Pichler, Martin, Greinix, Hildegard T, Stary, Georg, Ramsay, Alan G, Apollonio, Benedetta, Feichtinger, Julia, Beham-Schmid, Christine, Neumeister, Peter, Deutsch, Alexander J

“…Chemokine receptors and their ligands have been identified as playing an important role in the development of diffuse large B-cell lymphoma (DLBCL), follicular…”
Get full text

The CXCR4-CXCL12 -Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro by Pansy, Katrin, Feichtinger, Julia, Ehall, Barbara, Uhl, Barbara, Sedej, Miriam, Roula, David, Pursche, Beata, Wolf, Axel, Zoidl, Manuel, Steinbauer, Elisabeth, Gruber, Verena, Greinix, Hildegard T, Prochazka, Katharina T, Thallinger, Gerhard G, Heinemann, Akos, Beham-Schmid, Christine, Neumeister, Peter, Wrodnigg, Tanja M, Fechter, Karoline, Deutsch, Alexander Ja

“…In tumor cells of more than 20 different cancer types, the -axis is involved in multiple key processes including proliferation, survival, migration, invasion,…”
Get full text

Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy by Hatzl, Stefan, Posch, Florian, Rezai, Arwin, Gornicec, Maximilian, Beham-Schmid, Christine, Magnes, Theresa, Wangner, Sandro, Deutsch, Alexander, Greinix, Hildegard, Uhl, Barbara, Prochazka, Katharina T., Egle, Alexander, Greil, Richard, Melchardt, Thomas, Linkesch, Werner, Schulz, Eduard, Neumeister, Peter

“…Background A combination of rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard first-line therapy for diffuse…”
Get full text

Immunohistochemical double hit score enhances NCCN–IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma by Prochazka, Katharina T., Posch, Florian, Deutsch, Alexander, Beham‐Schmid, Christine, Stöger, Herbert, Abdyli, Leke, Greinix, Hildegard, Pichler, Martin, Neumeister, Peter

Get full text

A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups by Gao, Yuting, Wei, Li, Kim, Seok Jin, Wang, Liang, He, Yingzhi, Zheng, Yanfang, Bertero, Luca, Pellerino, Alessia, Cassoni, Paola, Tamagnone, Luca, Theresa, Prochazka Katharina, Deutsch, Alexander, Zhan, Huien, Lai, Jing, Wang, Yao, You, Hua

“…Primary central nervous system lymphoma (PCNSL) is a highly aggressive and rare extranodal non-Hodgkin lymphoma (NHL). The MSKCC and the IELSG scores represent…”
Get full text

NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes by Deutsch, Alexander J A, Rinner, Beate, Pichler, Martin, Prochazka, Katharina, Pansy, Katrin, Bischof, Marco, Fechter, Karoline, Hatzl, Stefan, Feichtinger, Julia, Wenzl, Kerstin, Frisch, Marie-Therese, Stiegelbauer, Verena, Prokesch, Andreas, Krogsdam, Anne, Sill, Heinz, Thallinger, Gerhard G, Greinix, Hildegard T, Wang, Chenguang, Beham-Schmid, Christine, Neumeister, Peter

“…Nuclear orphan receptor NR4A1 exerts an essential tumor suppressor function in aggressive lymphomas. In this study, we investigated the hypothesized…”
Get full text

The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma by Hatzl, Stefan, Posch, Florian, Schulz, Eduard, Gornicec, Maximilian, Deutsch, Alexander, Beham-Schmid, Christine, Pichler, Martin, Greinix, Hildegard, Sill, Heinz, Zebisch, Armin, Neumeister, Peter, Prochazka, Katharina T.

Get full text

Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas by Uhl, Barbara, Prochazka, Katharina T, Fechter, Karoline, Pansy, Katrin, Greinix, Hildegard T, Neumeister, Peter, Deutsch, Alexander Ja

“…Approximately 8% of all non-Hodgkin lymphomas are extranodal marginal zone B cell lymphomas of mucosa-associated lymphoid tissue (MALT), also known as MALT…”
Get full text

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients by Prochazka, Katharina T, Melchardt, Thomas, Posch, Florian, Schlick, Konstantin, Deutsch, Alexander, Beham-Schmid, Christine, Weiss, Lukas, Gary, Thomas, Neureiter, Daniel, Klieser, Eckhard, Greil, Richard, Neumeister, Peter, Egle, Alexander, Pichler, Martin

Get full text

Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B‐cell Lymphoma Patients: A Real‐world Perspective by Hatzl, Stefan, Kalmar, Peter, Posch, Florian, Riedl, Jakob M., Beham‐Schmid, Christine, Prochazka, Katharina, Greinix, Hildegard, Schwarz, Thomas, Gstettner, Christian, Neumeister, Peter, Schulz, Eduard

Get full text

Quantifying the driving factors for language shift in a bilingual region by Prochazka, Katharina, Vogl, Gero

“…Many of the world’s around 6,000 languages are in danger of disappearing as people give up use of a minority language in favor of the majority language in a…”
Get full text

Reetta Toivanen & Janne Saarikivi (eds.), Linguistic genocide or superdiversity? New and old language diversities. Bristol: Multilingual Matters, 2016. Pp. viii, 362. Hb. £99.95 by Prochazka, Katharina

Get full text

Best of hematology—2021 by Prochazka, Katharina Theresa

Get full text

Antibody–drug conjugates in the treatment of lymphoid neoplasms by Neumeister, Peter, Prochazka, Katharina Theresa

“…Summary Antibody-drug conjugates (ADCs) are a new class of monoclonal antibodies with the characteritic to specifically target tumor cells and to deliver a…”
Get full text

Bcl2 inhibitor venetoclax +/− Anti-CD20: what do deep remissions mean? by Prochazka, Katharina T., Uhl, Barbara

“…Summary In recent years, treatment of patients exhibiting chronic lymphocytic leukemia has changed extensively due to advances in the development of targeted…”
Get full text